New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Aberdeen Asia-Pacific Income Fund, Inc (NYSEMKT:FAX), Achillion Pharmaceuticals, Inc (NASDAQ:ACHN), Aeropostale Inc (NYSE:ARO), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)
Aberdeen Asia-Pacific Income Fund, Inc (NYSEMKT:FAX) showed a volume of 1.61 million shares by the end of last trade whereas the average volume of the stock remained 1.28 million shares. The stock opened the session at $5.86 but then moved to $5.97. At that price, the stock showed a positive performance of 1.88%. Aberdeen Asia-Pacific Income Fund, Inc. (the Fund) is a closed-end, non-diversified management investment company. The Fund’s principal investment objective is to seek current income. The Fund may also achieve incidental capital appreciation.
Will FAX Continue To Move Higher? Find Out Here
Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) opened the session at $4.21 and closed the session at $4.08. The stock showed a negative performance of -2.86% in previous trading session. Traded with volume of 1.61 million shares in the prior session and the average volume of the stock remained 2.29 million shares. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV),
Has ACHN Found The Bottom And Ready To Gain Momentum? Find Out Here
Aeropostale Inc (NYSE:ARO) opened the session at $7.61 and closed the session at $7.62. The stock showed a negative performance of -0.13% in previous trading session. Traded with volume of 1.60 million shares in the prior session and the average volume of the stock remained 3.25 million shares. The beta of the stock remained 1.15. Aeropostale, Inc., (Aeropostale) is a mall-based, specialty retailer of casual apparel and accessories, principally targeting 14 to 17 year-old young women and men through its Aeropostale stores and 4 to 12 year-old kids through its P.S. from Aeropostale stores. P.S. from Aeropostale products can be purchased in P.S. from Aeropostale stores,
Why Should Investors Buy ARO After the Recent Fall? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) the stock decreased -3.39% and finished the session at $3.71. Traded with volume of 1.60 million shares in the prior session and the average volume of the stock remained 3.26 million shares. The beta of the stock remained 1.36. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)